Stephen Gottschalk, MD
St. Jude Children's Research Hospital · Baylor College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Stephen Gottschalk, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:23 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04881240 · Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ LeukemiaSt. Jude Children's Research Hospital · recruiting · Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory, Pediatric ALL · principal investigator
- Ph1/Ph2NCT01512888 · Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed InfantsSt. Jude Children's Research Hospital · suspended · Severe Combined Immunodeficiency Disease, X-linked · principal investigator
- N/ANCT00695279 · Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked ProductsSt. Jude Children's Research Hospital · completed · Severe Combined Immunodeficiency, Malignancy, Hematologic, Neuroblastoma · principal investigator
- Ph1NCT00515957 · Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)Baylor College of Medicine · withdrawn · NASOPHARYNGEAL CARCINOMA · principal investigator
- Ph1NCT00516087 · LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)Baylor College of Medicine · completed · Nasopharyngeal Carcinoma · principal investigator
- Ph1NCT00078546 · EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)Baylor College of Medicine · completed · Nasopharyngeal Cancer, EBV Infections · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Lentiviral Gene Therapy and Genome Editing for Wiskott-Aldrich SyndromeP01HL053749 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI David J Rawlings · fiscal years 1994 to 2022Named on NCT01512888
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.